Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy

European Journal of Ophthalmology

Volumn 14, Issue 3, 2004, Pages 245-257

  Costello, F ^a   Zimmerman, M B ^b   Podhajsky, P A ^a   Hayreh, Sohan S ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Anterior ischemic optic neuropathy; Erythrocyte sedimentation rate; Giant cell arteritis; Platelets; Temporal arteritis; Thrombocytosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD VESSEL BIOPSY; CORTICOSTEROID THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HEMATOCRIT; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TEMPORAL ARTERY; THROMBOCYTE COUNT; THROMBOCYTOSIS; BIOPSY; DIFFERENTIAL DIAGNOSIS; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; TEMPORAL ARTERITIS;

AGED; AGED, 80 AND OVER; BIOPSY; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; THROMBOCYTOSIS;

EID: 3142520025     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400310     Document Type: Article

References (37)

1. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123: 285-96.
2. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: Ocular manifestations. Am J Ophthalmol 1998; 125: 521-6, 893.
3. Kearns TP. Collagen and rheumatic diseases: Ophthalmic aspects, In: Mausolf FA, editor. The Eye and Systemic Disease. St. Louis: Mosby, 1975: 105-18.
4. Olhagen B. Polymyalgia rheumatic: A form of senile arteritis? Acta Rheum Scand 1963; 9: 157-64.
5. Malmvall BE, Bengtsson BA. Giant cell arteritis: Clinical features and involvement of different organs. Scand J Rheumatol 1978; 7: 154-8.
6. Bergström AL, Bengtsson BA, Olsson LB, et al. Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy. Ann Rheum Dis 1979; 38: 244-7.
7. Giordano M. Thrombocytosis in giant cell arteritis. Ann Rheum Dis 1980; 39: 298.
8. Calamia KT, Hunder GG. Clinical manifestations of giant-cell (temporal) arteritis. Clin Rheum Dis 1980; 6: 389-403.
9. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24: 1414-8.
10. Riddle JM, Bluhm GB, Pitchford WC, et al. A comparative study of platelet reactivity in arthritis. Ann N Y Acad Sci 1981; 370: 22-9.
11. Bengtsson BA. Hematological observations in giant cell arteritis. Acta Med Scand 1982; Suppl 658: 44-7.
12. De Keyser J, De Klippel N, Ebinger G. Thrombocytosis and ischemic complications in giant cell arteritis. Br Med J 1991; 303: 825.
13. Price N, Clearkin LG. Thrombocytosis and giant cell arteritis. Lancet. 1994; 343: 672.
14. Krishna R, Kosmorsky GS. Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol 1997; 124: 103.
15. González-Gay MA, García-Porrua C, Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998; 25: 1750-5.
16. Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis rising platelet counts: A red flag for giant cell arteritis. J Neuroophthalmol 2000; 20: 67-72.
17. Hu Z, Yang Q, Zheng S, et al. Temporal arteritis and fever: Report of a case and a clinical reanalysis of 360 Cases. Angiology 2000; 51: 953-8.
18. Vrij AA, Rijken J, van Wersch JWJ, Stockbrügger RW. Platelet factor 4 and β-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 2000; 30: 188-94.
19. Gonzales-Alegre P, Ruiz-Lopez AD, Abarca-Costalago M, Gonzalez-Santos P. Increment of the platelet count in temporal arteritis: Response to therapy and ischemic complications. Eur Neurol 2001; 45: 43-45.
20. Liozon E, Herrmann F, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: A prospective study of 174 patients. Am J Med 2001; 111: 211-7.
21. Foroozan R, Danesh-Meyer H, Savino PJ, et al. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002; 109: 1267-71.
22. Gibb WRG, Urry PA, Lees AJ. Giant cell arteritis with spinal cord Infarction and basilar artery thrombosis. J Neurol Neurosurg Psychiatry 1985; 48: 945-8.
23. Kaiser M, Weyand CM, Björnsson J, Goronzy JJ. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998; 41: 623-33.
24. Cid MC, Font C, Oristrell J, de la Sierra A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 26-32.
25. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis: Report of a large study and review of literature. Acta Ophthalmol Scand 2002; 80: 355-67.
26. Hayreh SS, Zimmerman B. Management of giant cell arteritis: Our 27-Year Clinical Study; New Light on Old Controversies. Ophthalmologica 2003; 217: 239-59.
27. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003; 110: 1204-15.
28. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118: 766-80.
29. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125: 509-20.
30. Harrell FE. Chapter 23: The LOGIST Procedure, SUGI Supplemental Library User's Guide, Version 5 Edition, SAS Institute Inc., Cary, NC, 1986; 269-93.
31. Moncada S, Vanse JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. New Engl J Med 1979; 300: 1142-7.
32. Wu KK. Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med 1978; 88: 7-11.
33. Hayreh SS. Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol 1974; 58: 964-80.
34. Hayreh SS. Anterior ischaemic optic neuropathy: Differentiation of arteritic from non-arteritic type and its management. Eye 1990; 4: 25-41.
35. Singh S, Hayreh SS, Dass R. The central artery of the retina I. Origin and course. Br J Ophthalmol 1960; 44: 193-212.
36. Russell RWR. Giant cell arteritis. QJM 1959; 28: 471-89.
37. Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol 2002; 29 (Suppl): S16-21.